Janux Therapeutics logo

Janux Therapeutics Share Price Today

(NASDAQ: JANX)

Janux Therapeutics share price is $43.48 & ₹3,767.11 as on 1 Feb 2025, 2.30 'hrs' IST

$43.48

-1.31

(-2.92%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Janux Therapeutics share price in Dollar and Rupees. Guide to invest in Janux Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Janux Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Janux Therapeutics share price movements

  • Today's Low: $42.57
    Today's High: $46.10

    Day's Volatility :7.65%

  • 52 Weeks Low: $7.79
    52 Weeks High: $71.71

    52 Weeks Volatility :89.14%

Janux Therapeutics (JANX) Returns

PeriodJanux Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-22.18%
-0.6%
0.0%
6 Months
16.79%
-2.8%
0.0%
1 Year
422.6%
3.3%
0.0%
3 Years
191.42%
11.6%
-13.7%

Janux Therapeutics (JANX) Key Statistics

in dollars & INR

Previous Close
$44.79
Open
$44.99
Today's High
$46.095
Today's Low
$42.57
Market Capitalization
$2.6B
Today's Volume
$665.6K
52 Week High
$71.71
52 Week Low
$7.79
Revenue TTM
$13.0M
EBITDA
$-83.9M
Earnings Per Share (EPS)
$-1.17
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-12.05%

How to invest in Janux Therapeutics Stock (JANX) from India?

It is very easy for Indian residents to invest directly in Janux Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Janux Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Janux Therapeutics or JANX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Janux Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Janux Therapeutics shares which would translate to 0.020 fractional shares of Janux Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Janux Therapeutics, in just a few clicks!

Returns in Janux Therapeutics (JANX) for Indian investors in Rupees

The Janux Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Janux Therapeutics investment value today

Current value as on today

₹5,27,156

Returns

₹4,27,156

(+427.16%)

Returns from Janux Therapeutics Stock

₹4,22,596 (+422.6%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Janux Therapeutics (JANX)

-52.8%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Investment in Janux Therapeutics Shares from India has dropped by -52.8% over the past 30 days, indicating reduced transactional activity.

-81%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Janux Therapeutics Stock from India on INDmoney has decreased by -81% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Janux Therapeutics

  • RA Capital Management, LLC

    15.63%

  • FMR Inc

    13.35%

  • HHG PLC

    4.30%

  • BlackRock Inc

    4.13%

  • Paradigm Biocapital Advisors LP

    4.09%

  • Adage Capital Partners Gp LLC

    3.54%

Analyst Recommendation on Janux Therapeutics

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Janux Therapeutics(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
13
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Janux Therapeutics Stock (JANX)

What analysts predicted

Upside of 104.87%

Target:

$89.08

Current:

$43.48

Insights on Janux Therapeutics Stock (Ticker Symbol: JANX)

  • Price Movement

    In the last 1 year, JANX stock has moved up by 412.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 8.89M → 439.0K (in $), with an average decrease of 95.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -5.95M → -28.05M (in $), with an average decrease of 370.9% per quarter

Janux Therapeutics Technicals Summary

Sell

Neutral

Buy

Janux Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Janux Therapeutics (JANX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Janux Therapeutics Inc logo
-18.33%
16.79%
422.6%
191.42%
56.46%
Biontech Se logo
7.35%
57.95%
33.59%
-31.3%
308.89%
Regeneron Pharmaceuticals, Inc. logo
-5.9%
-37.18%
-28.8%
8.05%
97.29%
Vertex Pharmaceuticals Incorporated logo
13.78%
-3.19%
8.71%
82.07%
100.29%
Alnylam Pharmaceuticals, Inc. logo
16.13%
2.38%
56.77%
86.78%
136.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Janux Therapeutics Inc logo
NA
NA
NA
-1.3
-0.12
-0.1
NA
12.54
Biontech Se logo
160.8
NA
0.04
-3.32
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.89
16.89
1.06
44.96
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.15
0.49
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Janux Therapeutics Inc logo
Buy
$2.6B
56.46%
NA
0.0%
Biontech Se logo
Buy
$29.0B
308.89%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$75.1B
97.29%
16.89
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$112.9B
100.29%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.7B
136.62%
NA
-15.86%

Janux Therapeutics Dividend announcements

  • Janux Therapeutics Earnings

    Janux Therapeutics’s price-to-earnings ratio stands at None

    Read More

About Janux Therapeutics

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Organization
Janux Therapeutics
Employees
76
CEO
Dr. David Alan Campbell Ph.D.
Industry
Services

Management People of Janux Therapeutics

NameTitle
Dr. David Alan Campbell Ph.D.
President, CEO & Director
Mr. Charles M. Winter
Chief Technical Officer
Mr. Byron Robinson J.D., Ph.D.
Chief Strategy Officer
Mr. Matt Whitmire
Vice President of Finance
Ms. Maria Dobek
Principal Accounting Officer & VP of Accounting
Dr. Tommy Diraimondo Ph.D.
Chief Scientific Officer
Mr. James Pennington
General Counsel
Mr. Andy Hollman Meyer
Chief Business Officer

Important FAQs about investing in JANX Stock from India :

What is Janux Therapeutics share price today?

Janux Therapeutics share price today stands at $43.48, Open: $44.99 ; Previous Close: $44.79 ; High: $46.10 ; Low: $42.57 ; 52 Week High: $71.71 ; 52 Week Low: $7.79.

The stock opens at $44.99, after a previous close of $44.79. The stock reached a daily high of $46.10 and a low of $42.57, with a 52-week high of $71.71 and a 52-week low of $7.79.

Can Indians buy Janux Therapeutics shares?

Yes, Indians can invest in the Janux Therapeutics (JANX) from India.

With INDmoney, you can buy Janux Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Janux Therapeutics at zero transaction cost.

How can I buy Janux Therapeutics shares from India?

It is very easy to buy Janux Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Janux Therapeutics (JANX) be purchased?

Yes, you can buy fractional shares of Janux Therapeutics with INDmoney app.

What are the documents required to start investing in Janux Therapeutics stocks?

To start investing in Janux Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Janux Therapeutics Stock (JANX)?

Today’s highest price of Janux Therapeutics (JANX) is $46.10.

Today’s lowest price of Janux Therapeutics (JANX) is $42.57.

What is today's market capitalisation of Janux Therapeutics?

Today's market capitalisation of Janux Therapeutics JANX is 2.6B

What is the 52 Week High and Low Range of Janux Therapeutics Stock (JANX)?

  • 52 Week High

    $71.71

  • 52 Week Low

    $7.79

What are the historical returns of Janux Therapeutics (JANX)?

  • 1 Month Returns

    -18.33%

  • 3 Months Returns

    16.79%

  • 1 Year Returns

    422.6%

  • 5 Years Returns

    56.46%

Who is the Chief Executive Officer (CEO) of Janux Therapeutics ?

Dr. David Alan Campbell Ph.D. is the current Chief Executive Officer (CEO) of Janux Therapeutics.